Optimal designs for dose-escalation trials and individual allocations in cohorts
type: Item
instance of: scholarly article
title: Optimal designs for dose-escalation trials and individual allocations in cohorts
zbMATH Open document ID: 1497.62280
author: Anthony C. Atkinson
author: Nuno M. C. Oliveira
author: Belmiro P. M. Duarte
published in: Statistics and Computing
publication date: 2022-10-18T00:00:00Z
Mathematics Subject Classification ID: 62P10
Mathematics Subject Classification ID: 62K05
Mathematics Subject Classification ID: 62-08
Mathematics Subject Classification ID: 90C47
zbMATH DE Number: 7603003
zbMATH Keywords: dose escalation experiments
zbMATH Keywords: cohorts
zbMATH Keywords: first-in-human trials
zbMATH Keywords: optimal allocation
zbMATH Keywords: prognostic factors
describes a project that uses: CONOPT
describes a project that uses: GAMS
MaRDI profile type: Publication
full work available at URL: s11222-022-10158-3
OpenAlex ID: W4303985945
cites work: Designs with Partial Factorial Balance
cites work: Optimum biased coin designs for sequential clinical trials with prognostic factors
cites work: The Comparison of Designs for Sequential Clinical Trials with Covariate Information
cites work: Q3445852
cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials
cites work: A Treatment Allocation Procedure for Sequential Clinical Trials
cites work: Global optimization problems in optimal design of experiments in regression models
cites work: Coherence principles in dose-finding studies
cites work: Optimal Designs for Dose-Finding Studies
cites work: Dynamic Treatment Allocation Adjusting for Prognostic Factors for More Than Two Treatments
cites work: CONOPT: A GRG code for large sparse dynamic nonlinear optimization problems
cites work: Optimal exact designs of experiments via mixed integer nonlinear programming
cites work: The construction of optimal designs for dose-escalation studies
cites work: Optimal designs for comparing test treatments with controls. With comments and a rejoinder by the authors
cites work: Differentiating the pseudo determinant
cites work: Q4389333
cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
cites work: Q4849481
cites work: Optimal approximate designs for comparison with control in dose-escalation studies
cites work: On inverting circulant matrices
cites work: Statistical Issues in Drug Development
cites work: Q4061810
cites work: Properties of biased coin designs in sequential clinical trials
cites work: Q3687543
cites work: Design and Analysis of Phase I Clinical Trials
cites work: Convexification and global optimization in continuous and mixed-integer nonlinear programming. Theory, algorithms, software, and applications
cites work: Symmetry breaking in mixed integer linear programming formulations for blocking two-level orthogonal experimental designs
cites work: Q4649020
DOI: 10.1007/S11222-022-10158-3
Recommended article: The construction of optimal designs for dose-escalation studies
Recommended article: Optimal Designs for Dose-Finding Studies
Recommended article: On recent advances in optimal allocation designs in clinical trials
Recommended article: Optimal approximate designs for comparison with control in dose-escalation studies
Recommended article: Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes
Recommended article: Optimal allocation of patients in titration to fixed dose trials
Recommended article: Q4699449
Recommended article: A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity
Recommended article: Implementing optimal allocation in clinical trials with multiple endpoints
description: scientific article; zbMATH DE number 7603003